You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

anti-hemolysis effect of hydroxyurea

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial (Tetanus Toxoid Vaccine, Hydroxyurea, Didanosine)

Withdrawn
  • HIV Infections
  • Tetanus Toxoid Vaccine
  • +2 more
  • (no location specified)
Oct 28, 2021

Priapism Due to Sickle Cell Disease Trial in Kano (Tadalafil, Hydroxyurea, Placebo)

Recruiting
  • Priapism Due to Sickle Cell Disease
  • Kano, Nigeria
  • +1 more
Aug 23, 2022

Sickle Cell Disease Trial in Jinja (Hydroxyurea)

Recruiting
  • Sickle Cell Disease
  • Jinja, Uganda
    Jinja Regional Referral Hospital (JRRH), Department of Paediatri
Dec 14, 2022

Transfusion of Whole Blood in Acute Bleeding

Enrolling by invitation
  • Blood Transfusion
  • Acute Bleeding
  • Whole blood transfusion
  • Örebro, Sweden
    Örebro University
Aug 24, 2023

Hydroxyurea Exposure Limiting Pregnancy and Follow-Up Lactation

Recruiting
  • Sickle Cell Disease
  • Sickle Cell Anemia
  • Chart Review
  • Survey
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 8, 2021

Polycythemia Vera Trial in Tianjin (Ruxolitinib, Pegylated interferon a-2b)

Recruiting
  • Polycythemia Vera
  • Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
May 19, 2023

Hemolysis During Pulsed-field and Radiofrequency Ablation

Not yet recruiting
  • Atrial Fibrillation
  • +2 more
  • Pulsed-field ablation
  • Radiofrequency ablation
  • Prague, Czechia
    Cardiocenter, 3rd Medical School, Charles University and Univers
Oct 20, 2023

Thalassemia, Beta Trial in Karachi (Hydroxyurea and Thalidomide)

Completed
  • Thalassemia, Beta
  • Hydroxyurea and Thalidomide
  • Karachi, Sindh, Pakistan
    Children's Hospital Karachi
Nov 23, 2023

Sickle Cell Disease Trial in Worldwide (VIT-2763 120 mg, VIT-2763 360 mg, VIT-2763 240 mg)

Recruiting
  • Sickle Cell Disease
  • VIT-2763 120 mg
  • +4 more
  • Birmingham, Alabama
  • +12 more
Jan 20, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Cemdisiran, Eculizumab, Pozelimab)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
    Regeneron Research Facility
Jan 28, 2022

Paroxysmal Nocturnal Hemoglobinuria (PNH) Trial (MY008211A tablets)

Not yet recruiting
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)
  • MY008211A tablets
  • (no location specified)
Nov 17, 2023

Paroxysmal Nocturnal Hemoglobinuria Trial in Tianjin (MY008211A tablets)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • MY008211A tablets
  • Tianjin, Tianjin, China
    Nstitute of Hematology & Blood Disease Hospital, Chinese Academy
Sep 17, 2023

Sickle Cell Disease Trial in Atlanta (procedure, drug, other, radiation)

Recruiting
  • Sickle Cell Disease
  • Bone Marrow Transplant (BMT)
  • +7 more
  • Atlanta, Georgia
    Children's Healthcare of Atlanta
Sep 13, 2022

Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)

Completed
  • Iron Overload
  • +2 more
  • Omega 3
  • +5 more
  • Banī Suwayf, Egypt
  • +3 more
Jan 25, 2021

Paroxysmal Nocturnal Hemoglobinuria Trial in Whittier (Ravulizumab, Pozelimab, Cemdisiran)

Recruiting
  • Paroxysmal Nocturnal Hemoglobinuria
  • Whittier, California
  • +8 more
Nov 29, 2022

Autoimmune Haemolytic Anaemia Trial in Worldwide (BIVV020)

Active, not recruiting
  • Autoimmune Haemolytic Anaemia
  • Essen, Germany
  • +4 more
Jan 19, 2023

Polycythemia Vera Trial (Givinostat Hydrochloride, Hydroxy Urea)

Not yet recruiting
  • Polycythemia Vera
  • Givinostat Hydrochloride
  • Hydroxy Urea
  • (no location specified)
Oct 19, 2023

Anemia, Sickle Cell Trial in Cincinnati (Hydroxyurea)

Recruiting
  • Anemia, Sickle Cell
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Dec 7, 2021

Myelodysplastic/Myeloproliferative Tumor With Ring Sideroblasts and Thrombocytosis, Myelodysplastic/Myeloproliferative Tumor,

Recruiting
  • Myelodysplastic/Myeloproliferative Neoplasm With Ring Sideroblasts and Thrombocytosis
  • Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 6, 2023

Sickle Cell Disease Trial in United States (InCharge Health mobile application, HU Toolbox mobile application)

Completed
  • Sickle Cell Disease
  • InCharge Health mobile application
  • HU Toolbox mobile application
  • Augusta, Georgia
  • +6 more
Sep 26, 2022

Sickle Cell Anemia Trial in Kingston (Hydroxyurea)

Recruiting
  • Sickle Cell Anemia
  • Kingston, Jamaica
    Sickle Cell Unit
Jan 20, 2023

Endothelial Dysfunction, Hemolysis, Fluid Overload Trial in Amsterdam (A: gelofusine + ringers, B: albumine + ringers, C:

Not yet recruiting
  • Endothelial Dysfunction
  • +2 more
  • A: gelofusine + ringers
  • +2 more
  • Amsterdam, Noord Holland, Netherlands
    Amsterdam UMC, AMC location
Dec 9, 2022

Endothelial Dysfunction, Hemolysis, Fluid Overload Trial in Amsterdam (Treatment: additional albumin during cardiopulmonary

Not yet recruiting
  • Endothelial Dysfunction
  • +2 more
  • Treatment: additional albumin during cardiopulmonary bypass
  • control: additional ringers during cardiopulmonary bypass
  • Amsterdam, Noord Holland, Netherlands
    Amsterdam UMC, AMC location
Dec 9, 2022

Sickle Cell Anemia in Children, Sickle Cell Disease Trial in Luanda (Hydroxyurea)

Not yet recruiting
  • Sickle Cell Anemia in Children
  • Sickle Cell Disease
  • Luanda, Angola
    Hospital Geral dos Cajueiros
Jan 26, 2023

Sickle-Cell Anaemia Trial in Kinshasa (Hydroxyurea)

Completed
  • Sickle-Cell Anaemia
  • Kinshasa, Congo, The Democratic Republic of the
    University of Kinshasa
Dec 27, 2022